Robigo was founded by Andee Wallace, PhD in 2021.

Who are Robigo's investors?

Robigo's investors include Congruent Ventures, Endeavor8, First Star Ventures, Good Growth Capital, SUPPLY CHANGE CAPITAL, SVG Ventures | THRIVE, The E14 Fund, Aera VC and 3 more.

Robigo

Founded 2021 · 19 employees on LinkedIn · 11 known investors

Find your way into Robigo

Paths you didn't know you had: your email and LinkedIn already hold routes to the Robigo team. We find them for you
2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Robigo develops engineered microbial crop protection products for growers, including a biological solution targeting Sudden Death Syndrome in soybean. Its platform aims to deliver season-long yield protection against high-impact agricultural diseases while preserving beneficial organisms.

AgTech Biotech FoodTech

Founders & leadership

Robigo was founded in 2021 by Andee Wallace, PhD.

Andee Wallace, PhDFounder | Chief Executive Officer

Investors · 11

Congruent Ventureslisted by Congruent VenturesSan Francisco · $100K – $5M

How we know: Congruent Ventures's portfolio page · the VCSheet dataset · Not right? Tell us

Endeavor8listed by Endeavor8San Francisco

How we know: Endeavor8's portfolio page · a partner's Signal profile · Not right? Tell us

First Star Ventureslisted by First Star VenturesCambridge · $100K – $1M

How we know: agfundernews.com · the VCSheet dataset · open dataset · 5k.vc investor directory · Not right? Tell us

Good Growth Capitallisted by Good Growth CapitalCharleston

How we know: Good Growth Capital's portfolio page · the VCSheet dataset · open dataset · 5k.vc investor directory · Not right? Tell us

SUPPLY CHANGE CAPITALlisted by SUPPLY CHANGE CAPITALChicago · $200K – $1M

How we know: SUPPLY CHANGE CAPITAL's portfolio page · the VCSheet dataset · Not right? Tell us

SVG Ventures | THRIVElisted by SVG Ventures | THRIVESanta Clara · $10K – $100K

How we know: SVG Ventures | THRIVE's portfolio page · the VCSheet dataset · Not right? Tell us

The E14 Fundlisted by The E14 FundCambridge · $1M – $5M

How we know: The E14 Fund's portfolio page · the VCSheet dataset · Not right? Tell us

Aera VCreportedSingapore · $25K – $5M

How we know: the VCSheet dataset · Not right? Tell us

Morningside GroupreportedHong Kong

How we know: agfundernews.com · Not right? Tell us

SVG VenturesreportedSilicon Valley

How we know: funding news · Not right? Tell us

The Engine VenturesreportedCambridge

How we know: open dataset · 5k.vc investor directory · Not right? Tell us

Funding

SEC filings, press & company announcements

Undisclosed amountSeedFeb 2023
Source ↗
Undisclosed amountpre-seed fundingNov 2021
First Star Ventures, Morningside Group
Source ↗

Source: company announcements and press reports — follow each round's link for the claim.

Related companies · 6

bioBIO is the world's largest advocacy association representing biotechnology companies and research institutions across the United States and 30+ other nations. The organization facilitates industry networking through events, conferences, and partnering software while providing cost-savings programs and advocacy services for member companies.

BridgebioBridgeBio develops treatments for genetic conditions and cancers using a decentralized hub-and-spoke model, where autonomous teams focus on specific diseases or drug candidates while a central hub provides clinical, regulatory, and commercial support. The company partners with academic institutions to advance early-stage research toward late-stage clinical trials.

Korro BioKorro Bio is a biotechnology company developing a new class of RNA-editing therapies guided by human genetics and disease biology. It aims to create genetic medicines for patients with rare and highly prevalent debilitating or life-threatening diseases.

RubyRuby Bio develops biosynthesis technology and scale-up solutions for specialty chemicals, biofuels, and alternative proteins. The company serves manufacturers and food producers seeking sustainable, bio-derived alternatives to traditional chemical and protein sources.

RoosterBioA stem cell tools and technology company providing standardized platforms to accelerate regenerative medicine development and clinical trials.

ARTBIOARTBIO develops alpha radioligand therapies (ARTs) for cancer treatment, designing target-and-molecule combinations intended to kill tumors while sparing healthy tissue. The company covers the design, manufacture, and distribution of its therapies and builds on radiation research from the University of Oslo and Norway's Radium Hospital.

Companies working in the same space as Robigo.

In the news

Robigo Raises $6.85M in Seed Funding - FinSMEsfinsmes.com · Feb 2023

Frequently asked questions

What does Robigo do?: Robigo develops engineered microbial crop protection products for growers, including a biological solution targeting Sudden Death Syndrome in soybean. Its platform aims to deliver season-long yield protection against high-impact agricultural diseases while preserving beneficial organisms.
Who founded Robigo?: Robigo was founded by Andee Wallace, PhD in 2021.
Who are Robigo's investors?: Robigo's investors include Congruent Ventures, Endeavor8, First Star Ventures, Good Growth Capital, SUPPLY CHANGE CAPITAL, SVG Ventures | THRIVE, The E14 Fund, Aera VC and 3 more.